Abstract
Cardiovascular diseases (CVD) are the leading mortality cause in China due to rapidly aging population and unfavorable lifestyle change caused by urbanization. Elevated level of low-density lipoprotein cholesterol (LDL-C) is one of the key modifiable CVD risk factors. This study reviewed publications on epidemiology, disease burden, and treatment landscape related to dyslipidemia in China and compared findings with other advanced countries.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
